PART1 and pancreatic neoplasm: In order to assess the role of PART1 in pancreatic cancer, we performed qRT-PCR to detect its expression in 45 cases of pancreatic cancer patients, and found that the expression level of PART1 in cancer tissues was higher than that in para-tumor normal tissues (Fig. 1a, P < 0.01).